FP
BSX icon

Financial Perspectives’s Boston Scientific BSX Stock Holding History

Financial Perspectives’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.96M Buy
139,697
+5,127
+4% +$278K 1.45% 18
2026
Q1 		$8.44M Sell
134,570
-597
-0.4% -$47.8K 2.36% 13
2025
Q4 		$12.9M Sell
135,167
-1,000
-0.7% -$98K 3.47% 6
2025
Q3 		$13.3M Buy
136,167
+2,017
+2% +$209K 3.69% 6
2025
Q2 		$14.4M Sell
134,150
-3,042
-2% -$308K 4.36% 5
2025
Q1 		$13.8M Sell
137,192
-7,728
-5% -$778K 4.74% 5
2024
Q4 		$12.9M Sell
144,920
-1,413
-1% -$124K 4.35% 6
2024
Q3 		$12.3M Sell
146,333
-2,000
-1% -$158K 4.25% 6
2024
Q2 		$11.4M Buy
148,333
+2,203
+2% +$161K 4.22% 6
2024
Q1 		$10M Sell
146,130
-6
-0% -$386 3.79% 6
2023
Q4 		$8.45M Sell
146,136
-651
-0.4% -$34.8K 3.43% 6
2023
Q3 		$7.75M Hold
146,787
– – 3.55% 6
2023
Q2 		$7.94M Sell
146,787
-2,965
-2% -$155K 3.49% 6
2023
Q1 		$7.49M Sell
149,752
-1,366
-0.9% -$64.4K 3.58% 6
2022
Q4 		$6.99M Sell
151,118
-202
-0.1% -$8.75K 3.58% 6
2022
Q3 		$5.86M Hold
151,320
– – 3.29% 7
2022
Q2 		$5.64M Sell
151,320
-13,578
-8% -$553K 3.18% 7
2022
Q1 		$7.3M Sell
164,898
-2,000
-1% -$86.7K 3.41% 6
2021
Q4 		$7.09M Buy
166,898
+3,756
+2% +$158K 3.35% 8
2021
Q3 		$7.08M Sell
163,142
-1,513
-0.9% -$66.9K 3.57% 6
2021
Q2 		$7.04M Sell
164,655
-6,392,505
-97% -$269M 3.43% 6
2021
Q1 		$170M Buy
6,557,160
+6,384,405
+3,696% +$242M 8.43% 2
2020
Q4 		$6.21M Sell
172,755
-1,487
-0.9% -$53.6K 3.53% 6
2020
Q3 		$6.66M Sell
174,242
-9,350
-5% -$360K 4.38% 4
2020
Q2 		$6.45M Buy
183,592
+2,506
+1% +$90.2K 4.61% 4
2020
Q1 		$5.91M Buy
181,086
+3,760
+2% +$147K 4.78% 5
2019
Q4 		$8.02M Buy
+177,326
New +$7.42M 5.47% 4

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
MF
Milford Funds Auckland $6.14B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Financial Perspectives's BSX Position: Q2 2026 in Review

Financial Perspectives increased its Boston Scientific (BSX) stake by 3.8% in Q2 2026, buying an estimated $278K and bringing the position to 139,697 shares worth $5.96M. The position accounts for 1.45% of the portfolio, ranked #18.

Financial Perspectives first reported a position in BSX in Q4 2019 and has held it in 27 quarters since. The position peaked at $170M in Q1 2021. 499 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Financial Perspectives held 139,697 shares of Boston Scientific worth $5.96M as of Q2 2026.
  • Financial Perspectives bought 5,127 Boston Scientific shares in Q2 2026, an estimated $278K.
  • Boston Scientific made up 1.45% of Financial Perspectives's portfolio in Q2 2026, its #18 holding.
  • Financial Perspectives first reported a position in Boston Scientific in Q4 2019 and has held it in 27 quarters since.
  • Financial Perspectives's Boston Scientific position peaked at $170M in Q1 2021.
  • 499 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Financial Perspectives's 13F filing for Q2 2026, filed 24 Jul 2026.